Full Press Release Details
RETRACTABLE TECHNOLOGIES, INC. DECLARES
DIVIDENDS TO SERIES II CLASS B
CONVERTIBLE PREFERRED STOCK SHAREHOLDERS
LITTLE ELM, Texas, September 30, 2021-Retractable
Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II
Class B Convertible Preferred Stock in the amount of $39,050. The dividend amount is $0.25 per share. Dividends have accrued at 10%
per annum and cover amounts in arrears from July 1, 2021 through date of conversion or September 30, 2021 whichever is applicable.
The dividends will be paid on October 22, 2021 to shareholders of record as of the close of business on October 12, 2021.
Retractable manufactures and markets VanishPoint
and Patient Safe safety medical products and the EasyPoint needle. The VanishPoint syringe,
blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly
from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are uniquely designed
to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable
needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint
needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general
more information on Retractable, visit its website at www.retractable.com.
Forward-looking statements in this press release
are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable's current
views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate.
However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from
Factors that could cause or contribute to such
differences include, but are not limited to: the impact of COVID-19 on all facets of logistics and operations, as well as costs, Retractable's
ability to complete capital improvements and ramp up domestic production in response to government agreements, potential tariffs, Retractable's
ability to maintain liquidity; Retractable's maintenance of patent protection; Retractable's ability to maintain favorable third party
manufacturing and supplier arrangements and relationships; foreign trade risk; Retractable's ability to access the market; production
costs; the impact of larger market players in providing devices to the safety market; and other risks and uncertainties that are detailed
from time to time in Retractable's periodic reports filed with the U.S. Securities and Exchange Commission.
Retractable Technologies, Inc.
John W. Fort III, 888-806-2626 or 972-294-1010
Vice President, Chief Financial Officer, and Chief